Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 170


The role of epithelial-mesenchymal transition programming in invasion and metastasis: a clinical perspective.

Creighton CJ, Gibbons DL, Kurie JM.

Cancer Manag Res. 2013 Jul 31;5:187-95. doi: 10.2147/CMAR.S35171. eCollection 2013.


Downregulation of miR-153 contributes to epithelial-mesenchymal transition and tumor metastasis in human epithelial cancer.

Xu Q, Sun Q, Zhang J, Yu J, Chen W, Zhang Z.

Carcinogenesis. 2013 Mar;34(3):539-49. doi: 10.1093/carcin/bgs374. Epub 2012 Nov 27.


Role of microRNA in epithelial to mesenchymal transition and metastasis and clinical perspectives.

Díaz-López A, Moreno-Bueno G, Cano A.

Cancer Manag Res. 2014 Apr 25;6:205-16. doi: 10.2147/CMAR.S38156. eCollection 2014. Review.


Mesenchymal stem cells play a potential role in regulating the establishment and maintenance of epithelial-mesenchymal transition in MCF7 human breast cancer cells by paracrine and induced autocrine TGF-β.

Xu Q, Wang L, Li H, Han Q, Li J, Qu X, Huang S, Zhao RC.

Int J Oncol. 2012 Sep;41(3):959-68. doi: 10.3892/ijo.2012.1541. Epub 2012 Jul 3.


The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1.

Gregory PA, Bert AG, Paterson EL, Barry SC, Tsykin A, Farshid G, Vadas MA, Khew-Goodall Y, Goodall GJ.

Nat Cell Biol. 2008 May;10(5):593-601. doi: 10.1038/ncb1722. Epub 2008 Mar 30.


Epithelial-mesenchymal transition (EMT) in tumor-initiating cells and its clinical implications in breast cancer.

Creighton CJ, Chang JC, Rosen JM.

J Mammary Gland Biol Neoplasia. 2010 Jun;15(2):253-60. doi: 10.1007/s10911-010-9173-1. Epub 2010 Mar 31. Review.


Transcription factors associated with epithelial-mesenchymal transition and cancer stem cells in the tumor centre and margin of invasive breast cancer.

Alkatout I, Wiedermann M, Bauer M, Wenners A, Jonat W, Klapper W.

Exp Mol Pathol. 2013 Feb;94(1):168-73. doi: 10.1016/j.yexmp.2012.09.003. Epub 2012 Sep 15.


miR-200 expression regulates epithelial-to-mesenchymal transition in bladder cancer cells and reverses resistance to epidermal growth factor receptor therapy.

Adam L, Zhong M, Choi W, Qi W, Nicoloso M, Arora A, Calin G, Wang H, Siefker-Radtke A, McConkey D, Bar-Eli M, Dinney C.

Clin Cancer Res. 2009 Aug 15;15(16):5060-72. doi: 10.1158/1078-0432.CCR-08-2245. Epub 2009 Aug 11.


Cancer stem-like cells enriched with CD29 and CD44 markers exhibit molecular characteristics with epithelial-mesenchymal transition in squamous cell carcinoma.

Geng S, Guo Y, Wang Q, Li L, Wang J.

Arch Dermatol Res. 2013 Jan;305(1):35-47. doi: 10.1007/s00403-012-1260-2. Epub 2012 Jun 28.


The T-box transcription factor Brachyury regulates epithelial-mesenchymal transition in association with cancer stem-like cells in adenoid cystic carcinoma cells.

Shimoda M, Sugiura T, Imajyo I, Ishii K, Chigita S, Seki K, Kobayashi Y, Shirasuna K.

BMC Cancer. 2012 Aug 29;12:377. doi: 10.1186/1471-2407-12-377.


Snail2 is an essential mediator of Twist1-induced epithelial mesenchymal transition and metastasis.

Casas E, Kim J, Bendesky A, Ohno-Machado L, Wolfe CJ, Yang J.

Cancer Res. 2011 Jan 1;71(1):245-54. doi: 10.1158/0008-5472.CAN-10-2330.


MicroRNA-200b regulates cell proliferation, invasion, and migration by directly targeting ZEB2 in gastric carcinoma.

Kurashige J, Kamohara H, Watanabe M, Hiyoshi Y, Iwatsuki M, Tanaka Y, Kinoshita K, Saito S, Baba Y, Baba H.

Ann Surg Oncol. 2012 Jul;19 Suppl 3:S656-64. doi: 10.1245/s10434-012-2217-6. Epub 2012 Feb 4.


Metformin against TGFβ-induced epithelial-to-mesenchymal transition (EMT): from cancer stem cells to aging-associated fibrosis.

Cufí S, Vazquez-Martin A, Oliveras-Ferraros C, Martin-Castillo B, Joven J, Menendez JA.

Cell Cycle. 2010 Nov 15;9(22):4461-8. Epub 2010 Nov 15.


MiR-145 regulates epithelial to mesenchymal transition of breast cancer cells by targeting Oct4.

Hu J, Guo H, Li H, Liu Y, Liu J, Chen L, Zhang J, Zhang N.

PLoS One. 2012;7(9):e45965. doi: 10.1371/journal.pone.0045965. Epub 2012 Sep 26. Retraction in: PLoS One. 2013;8(5). doi: 10.1371/annotation/aaef10de-ee36-416f-93eb-959dfa3dc92e.


Snail1 induces epithelial-to-mesenchymal transition and tumor initiating stem cell characteristics.

Dang H, Ding W, Emerson D, Rountree CB.

BMC Cancer. 2011 Sep 19;11:396. doi: 10.1186/1471-2407-11-396.


The T box transcription factor TBX2 promotes epithelial-mesenchymal transition and invasion of normal and malignant breast epithelial cells.

Wang B, Lindley LE, Fernandez-Vega V, Rieger ME, Sims AH, Briegel KJ.

PLoS One. 2012;7(7):e41355. doi: 10.1371/journal.pone.0041355. Epub 2012 Jul 23.


Emerging targets in pancreatic cancer: epithelial-mesenchymal transition and cancer stem cells.

Castellanos JA, Merchant NB, Nagathihalli NS.

Onco Targets Ther. 2013 Sep 13;6:1261-7. doi: 10.2147/OTT.S34670. Review.


MiR-155-mediated loss of C/EBPβ shifts the TGF-β response from growth inhibition to epithelial-mesenchymal transition, invasion and metastasis in breast cancer.

Johansson J, Berg T, Kurzejamska E, Pang MF, Tabor V, Jansson M, Roswall P, Pietras K, Sund M, Religa P, Fuxe J.

Oncogene. 2013 Dec 12;32(50):5614-24. doi: 10.1038/onc.2013.322. Epub 2013 Aug 19.


MiR-652 inhibits acidic microenvironment-induced epithelial-mesenchymal transition of pancreatic cancer cells by targeting ZEB1.

Deng S, Li X, Niu Y, Zhu S, Jin Y, Deng S, Chen J, Liu Y, He C, Yin T, Yang Z, Tao J, Xiong J, Wu H, Wang C, Zhao G.

Oncotarget. 2015 Oct 19. doi: 10.18632/oncotarget.5350. [Epub ahead of print]

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk